These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24277050)

  • 1. Metronidazole and hydroxymetronidazole central nervous system distribution: 2. cerebrospinal fluid concentration measurements in patients with external ventricular drain.
    Frasca D; Dahyot-Fizelier C; Adier C; Mimoz O; Debaene B; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014; 58(2):1024-7. PubMed ID: 24277050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole and hydroxymetronidazole central nervous system distribution: 1. microdialysis assessment of brain extracellular fluid concentrations in patients with acute brain injury.
    Frasca D; Dahyot-Fizelier C; Adier C; Mimoz O; Debaene B; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014; 58(2):1019-23. PubMed ID: 24277041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
    Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain.
    Chauzy A; Nadji A; Combes JC; Defrance N; Bouhemad B; Couet W; Chavanet P
    J Antimicrob Chemother; 2019 Mar; 74(3):675-681. PubMed ID: 30535190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study.
    Stancil SL; van Haandel L; Abdel-Rahman S; Pearce RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():272-278. PubMed ID: 29933220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHARMACOKINETICS OF A SINGLE DOSE OF METRONIDAZOLE AFTER RECTAL ADMINISTRATION IN CAPTIVE ASIAN ELEPHANTS (ELEPHAS MAXIMUS).
    Sander SJ; Siegal-Willott JL; Ziegler J; Lee E; Tell L; Murray S
    J Zoo Wildl Med; 2016 Mar; 47(1):1-5. PubMed ID: 27010257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and skin blister fluid concentrations of metronidazole and its hydroxy metabolite after oral administration.
    Klimowicz A; Nowak A; Bielecka-Grzela S
    Pol J Pharmacol; 1996; 48(1):47-52. PubMed ID: 9112627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure of cyclosporin A in whole blood, cerebral spinal fluid, and brain extracellular fluid dialysate in adults with traumatic brain injury.
    Brophy GM; Mazzeo AT; Brar S; Alves OL; Bunnell K; Gilman C; Karnes T; Hayes RL; Bullock R
    J Neurotrauma; 2013 Sep; 30(17):1484-9. PubMed ID: 23540442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of cutaneous microdialysis to evaluate metronidazole and its main metabolite concentrations in the skin after a single oral dose.
    Bielecka-Grzela S; Klimowicz A
    J Clin Pharm Ther; 2003 Dec; 28(6):465-9. PubMed ID: 14651668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst.
    Pearce RE; Cohen-Wolkowiez M; Sampson MR; Kearns GL
    Drug Metab Dispos; 2013 Sep; 41(9):1686-94. PubMed ID: 23813797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of intravenous metronidazole in Asian surgical patients.
    Ti TY; Lee HS; Khoo YM
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2248-51. PubMed ID: 8891123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.
    Nau R; Sörgel F; Eiffert H
    Clin Microbiol Rev; 2010 Oct; 23(4):858-83. PubMed ID: 20930076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation.
    Wang LA; Gonzalez D; Leeder JS; Tyndale RF; Pearce RE; Benjamin DK; Kearns GL; Cohen-Wolkowiez M;
    J Clin Pharmacol; 2017 Feb; 57(2):230-234. PubMed ID: 27417511
    [No Abstract]   [Full Text] [Related]  

  • 15. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.
    Sprandel KA; Drusano GL; Hecht DW; Rotschafer JC; Danziger LH; Rodvold KA
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):303-9. PubMed ID: 16887471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain.
    Sime FB; Lassig-Smith M; Starr T; Stuart J; Pandey S; Parker SL; Wallis SC; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole excretion in human milk and its effect on the suckling neonate.
    Passmore CM; McElnay JC; Rainey EA; D'Arcy PF
    Br J Clin Pharmacol; 1988 Jul; 26(1):45-51. PubMed ID: 3203060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of Nifadin, Niprisan and Niprd/92/001/1-1 (AM-1) on the pharmacokinetics of metronidazole in rats.
    Bakare-Odunola MT; Mustapha KB; Garba M; Obodozie OO; Enemali IS
    Eur J Drug Metab Pharmacokinet; 2010 Sep; 35(1-2):55-8. PubMed ID: 21495267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy.
    Pea F; Pavan F; Nascimben E; Benetton C; Scotton PG; Vaglia A; Furlanut M
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3104-8. PubMed ID: 14506016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of metronidazole and its metabolites in reduced renal function.
    Bergan T; Thorsteinsson SB
    Chemotherapy; 1986; 32(4):305-18. PubMed ID: 3731917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.